References
- Planas M, Alvarez-Hernandez J, Leon-Sanz M, Celaya-Perez S., Araujo K, Garcia De Lorenzo A. Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study. Support Care Cancer. 2016; 24:429–435.
https://doi.org/10.1007/s00520-015-2813-7 - Arends J., Baracos V., Bertz H, F. Bozzetti, Calder P.C., Deutz N.E.P, Erickson N., Laviano A., Lisanti M.P., Lobo D.N., Mcmillan D.C., Muscaritoli M., Ockenga J., Pirlich M., Strasser F., De Van Der Schueren M. ESPEN expert group recommendations for action against cancer-related malnutrition, Clinical Nutrition, 2017; 36 (5): 1187–1196.
https://doi.org/10.1016/j.clnu.2017.06.017 - Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345–1350.
https://doi.org/10.1093/ajcn/83.6.1345 - Cederholm T., Barazzoni R., Austin P., Ballmer P., Biolo G., Bischoff S.C., Compher C., Correia I., Higashiguchi T., Holst M., Jensen G.L., Malone A., Muscaritoli M. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017; 36:49–64.
https://doi.org/10.1016/j.clnu.2016.09.004 - Lochs H., Allison S.P., Meier R., Pirlich M., Kondrup J., Schneider S., Van Den Berghe G., Pichard C. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2): 180–186.
https://doi.org/10.1016/j.clnu.2006.02.007 - Blauwhoff-Buskermolen S., Ruijgrok C., Ostelo R., De Vet H., Verheul H., De Van Der Schueren M. The assessment of anorexia in patients with cancer: Cut-off values for the FAACTA/CS and the VAS for appetite. Support Care Cancer 2016;24:661–666.
https://doi.org/10.1007/s00520-015-2826-2 - Hebuterne X., Lemarie E., Michallet M., De Montreuil C.B., Schneider S.M., Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38:196–204.
https://doi.org/10.1177/0148607113502674 - Pressoir M., Desne S., Berchery D., Rossignol G., Poiree B., Meslier M., Traversier S., Vittot M., Simon M., Gekiere J.P., Meuric J., Serot F., Falewee M.N. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–971.
https://doi.org/10.1038/sj.bjc.6605578 - Hamaker ME, van Huis-Tanja LH, Rostoft S. Optimizing the geriatrician’s contribution to cancer care for older patients. J Geriatr Oncol. 2019 (in press).
https://doi.org/10.1016/j.jgo.2019.06.018 - Martin L., Senesse P., Gioulbasanis I. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 2015; 33: 90–9.
- Del Fabbro E. Current and future care of patients with the cancer anorexia-cachexia syndrome. Am Soc Clin Oncol Educ Book 2015; e229–37.
https://doi.org/10.14694/edbook_am.2015.35.e229 - Gonzalez M.C., Barbosa-Silva T.G., Bielemann R.M., Gallagher D., Heymsfield S.B.: Phase angle and its determinants in healthy subjects: influence of body composition Am J Clin Nutr. 2016;103(3):712–6.
https://doi.org/10.3945/ajcn.115.116772 - Bosy-Westphal A., Danielzik S., Dörhöfer R.P., Later W., Wiese S., Müller M.J. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN 2006;30:309–316.
https://doi.org/10.1177/0148607106030004309 - Lee S.Y., Lee Y.., Yang J.H., Kim C.M., Choi W.S. The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary Study. Korean J Fam Med 2014;35:251–256.
https://doi.org/10.4082/kjfm.2014.35.5.251 - Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008;8:249.
https://doi.org/10.1186/1471-2407-8-249 - Muscaritoli M. Perspectives of health care professionals on cancer cachexia: results from three global surveys. Ann Oncol. 2016;27(12):2230–2236.
https://doi.org/10.1093/annonc/mdw420 - Nishioka N., Uchino J., Hirai S. Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer. J Clin Med. 2019;8(4):450.
https://doi.org/10.3390/jcm8040450 - Boshier P.R., Henegan R., Markar S.R., Baracos V.E., Low D.E. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Diseases of the Esophagus. 2018;31(8):1040–47.
https://doi.org/10.1093/dote/doy089.ps02.248 - Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003;22(3):235–9.
https://doi.org/10.1016/s0261-5614(02)00215-7 - Koch C., Reitz C., Schrekenbach T. Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma. Plos One 2019;14(10):e0223613.
https://doi.org/10.1371/journal.pone.0223613